Variant report
Variant | nsv981934 |
---|---|
Chromosome Location | chr8:47470026-47502214 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:47168205..47168775-chr8:47479656..47480472,2 | MCF-7 | breast: | |
2 | chr8:47487702..47490248-chr8:47515594..47517867,2 | K562 | blood: | |
3 | chr8:47491632..47493538-chr8:47505350..47507971,2 | K562 | blood: | |
4 | chr8:47484279..47485112-chr8:47579488..47580411,3 | MCF-7 | breast: | |
5 | chr8:47144016..47144925-chr8:47484500..47485152,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531698527 | chr8:47477606-47477607 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148820445 | chr8:47477631-47477632 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571634440 | chr8:47477644-47477645 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113289517 | chr8:47477656-47477657 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547700383 | chr8:47477675-47477676 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375570826 | chr8:47477684-47477685 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567448151 | chr8:47477689-47477690 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28781924 | chr8:47477726-47477727 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs556403742 | chr8:47477740-47477741 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182749686 | chr8:47477816-47477817 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189023861 | chr8:47477874-47477875 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192344131 | chr8:47477875-47477876 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142473637 | chr8:47477879-47477880 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569646840 | chr8:47477884-47477885 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540646646 | chr8:47477921-47477922 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184729908 | chr8:47477934-47477935 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528934665 | chr8:47477975-47477976 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13278289 | chr8:47477979-47477980 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560887799 | chr8:47477981-47477982 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191493108 | chr8:47484415-47484416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183194886 | chr8:47484416-47484417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369318528 | chr8:47484421-47484422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138038693 | chr8:47484505-47484506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142221392 | chr8:47484535-47484536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201400380 | chr8:47484590-47484591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562222404 | chr8:47486416-47486417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531177234 | chr8:47486427-47486428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75101430 | chr8:47486431-47486432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564655107 | chr8:47486447-47486448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533272569 | chr8:47486459-47486460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs377246701 | chr8:47486509-47486510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546657904 | chr8:47486529-47486530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs74578579 | chr8:47486553-47486554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529678009 | chr8:47486566-47486567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566563783 | chr8:47486578-47486579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185523765 | chr8:47486587-47486588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548915530 | chr8:47486621-47486622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569046273 | chr8:47486645-47486646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143843592 | chr8:47486662-47486663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560458747 | chr8:47486689-47486690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532363627 | chr8:47486701-47486702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552360217 | chr8:47486728-47486729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374437131 | chr8:47486759-47486760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367762611 | chr8:47486764-47486765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557668130 | chr8:47486835-47486836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571389099 | chr8:47486854-47486855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10112598 | chr8:47486893-47486894 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs114594331 | chr8:47486926-47486927 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146388904 | chr8:47486934-47486935 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542641057 | chr8:47486936-47486937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Oral cancer | 21386901 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:47477600-47477800 | Active TSS | Monocytes-CD14+_RO01746 | blood |
2 | chr8:47477800-47478000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
3 | chr8:47484400-47484600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr8:47486400-47486800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr8:47486400-47488800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
6 | chr8:47486800-47487800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
7 | chr8:47487800-47488600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr8:47488000-47488800 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
9 | chr8:47488600-47490200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
10 | chr8:47488800-47489800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
11 | chr8:47489800-47491200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
12 | chr8:47490200-47490800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
13 | chr8:47498200-47498600 | Enhancers | Placenta | Placenta |